Chronic obstructive pulmonary disease may be associated with higher rates of mortality in patients with coronavirus disease 2019.
Children with severe or poorly controlled asthma with allergen sensitization have been shown to experience more asthma exacerbations and use more oral corticosteroids compared with those without allergen sensitization.
Results from PNEU-PATH demonstrated comparable immune responses following vaccination with Pneumovax 23 in both treatment groups for the 15 serotypes in V114.
The FDA approved therapies to treat pain, type 2 diabetes, hormone deficiency, and juvenile idiopathic arthritis in September 2020.
Patients with interstitial lung disease have an increased risk of severe disease and death associated with COVID-19.
Researchers aimed to assess changes in the prevalence of tobacco use among patients with mental illness who were admitted to a tobacco-free inpatient psychiatric facility.
The FDA has implemented a premarket review process for e-cigarette products in an effort to continue the decline of youth e-cigarette use in the US.
Implementation of the Hospital Readmission Reduction Program was associated with a decrease in 30-day readmissions in patients with COPD following their hospital discharge.
The findings of a preliminary analysis suggest that COVID-19 may not be characterized by cytokine storm and therefore the benefit of anticytokine therapies remains to be determined.
Recommendations are presented for the use of noninvasive ventilation for patients with COPD and chronic hypercapnia in an American Thoracic Society clinical practice guideline.
Pneumothorax is being reported as a complication of COVID-19, and has higher incidence among men and lower survival among older patients.
Patients treated with tocilizumab were 44% less likely to progress to mechanical ventilation or death compared with placebo.
The 12-month history of acute exacerbations used to guide most COPD treatment relies on an unstable frequent exacerbator phenotype.
Cannabidiol (CBD) may be a safe and effective treatment option for cannabis use disorder.
People with asthma were not overrepresented in patients with severe pneumonia because of SARS-CoV-2 infection who required hospitalization.
ASTHMAXcel Adventures is a gamified, guideline-based, pediatric mobile application that improves asthma control, knowledge, and quality of life, and reduces emergency department visits.
A deep learning model based on chest radiograph images and electronic medical record data shows promise for smokers at high risk for lung cancer
The list, titled “Five Things Physicians and Patients Should Question,” was developed by members of the AAP Section on Pediatric Pulmonology and Sleep Medicine.
Patients with obstructive or central sleep apnea experienced improvements in apnea-hypopnea index following treatment with acetazolamide.
Researchers believe traffic fatalities may have increased in Colorado due to the state’s cannabis tourism industry, which is not as robust in Washington State.